Pear Therapeutics, Inc.
PEAR · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $60 | $60 | $89 |
| Short-Term Investments | $11 | $24 | $47 | $48 |
| Receivables | $7 | $7 | $5 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $8 | $8 | $9 |
| Total Curr. Assets | $73 | $99 | $121 | $150 |
| Property Plant & Equip (Net) | $15 | $16 | $16 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $5 | $5 | $5 |
| Total NC Assets | $22 | $21 | $22 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $95 | $120 | $143 | $172 |
| Liabilities | – | – | – | – |
| Payables | $3 | $1 | $2 | $4 |
| Short-Term Debt | $29 | $29 | $29 | $29 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $1 |
| Other Curr. Liab. | $16 | $17 | $15 | $13 |
| Total Curr. Liab. | $49 | $48 | $47 | $46 |
| LT Debt | $8 | $9 | $9 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $11 | $7 | $47 |
| Total NC Liab. | $15 | $19 | $17 | $56 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $65 | $67 | $63 | $103 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$323 | -$297 | -$266 | -$272 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $354 | $349 | $346 | $341 |
| Total Equity | $31 | $52 | $79 | $70 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $95 | $120 | $143 | $172 |
| Net Debt | -$11 | -$22 | -$22 | -$51 |